ARDEN HILLS, MN, Medical device startup Cryosa completed its Series B funding round, raising $21.5 million to continue development of its therapies for obstructive sleep apnea (OSA).
The round was led by life sciences firm Solas BioVentures, with additional funding from Series A investors which include life sciences firm SantÃ© Ventures, global technology and med-tech company HOYA Corporation, and additional investors. The funding will be used to continue first-in-human clinical trials.
Cryosa is a medical device company focused on developing breakthrough, minimally invasive therapies for obstructive sleep apnea (OSA) that do not require daily patient compliance. Driven by an experienced medical device team of successful startup entrepreneurs and large med-tech engineers and professionals, the company is based in Minnesota's Medical Alley.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about